tiprankstipranks
Nautilus Biotechnolgy (NAUT)
NASDAQ:NAUT
US Market
Holding NAUT?
Track your performance easily

Nautilus Biotechnolgy (NAUT) Ownership - Who Owns Nautilus Biotechnolgy?

120 Followers

Nautilus Biotechnolgy (NAUT) Ownership Overview

42.95%3.76%41.86%4.43%6.99%
42.95% Insiders
41.86% Other Institutional Investors
4.43% ETFs
6.99% Public Companies and
Individual Investors
The ownership structure of Nautilus Biotechnolgy (NAUT) stock is a mix of institutional, retail, and individual investors. Approximately 50.06% of the company’s stock is owned by Institutional Investors, 42.95% is owned by Insiders, and 6.99% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 25, 2024
Godwin Mary E.
Svp Operations
xxxxxxxxxxxxx
$134509
Sep 18, 2024
Godwin Mary E.
Svp Operations
xxxxxxxxxxxxx
$99750
Mar 11, 2024
Sujal M Patel
Ceo, President, And Secretary,director, >10% Owner
xxxxxxxxxxxxx
$41446
Mar 07, 2024
Sujal M Patel
Ceo, President, And Secretary,director, >10% Owner
xxxxxxxxxxxxx
$98870

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
20,479,892Insider16.31%45,874,958
17,158,999Insider13.67%38,436,158
12,594,211Institution10.03%28,211,033
9,111,151Insider7.26%20,408,978
6,479,845Insider5.16%14,514,853
2,674,776Institution2.13%5,991,498
2,638,278Institution2.10%5,909,743
2,415,222Institution1.92%5,410,097
546,621Institution0.44%1,224,431
506,195Institution0.40%1,133,877

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,415,222Institution1.92%5,410,097
546,621Institution0.44%1,224,431
506,195Institution0.40%1,133,877
327,779Institution0.26%734,225
326,358Institution0.26%731,042
231,803Institution0.18%519,239
137,487Institution0.11%307,971
67,847Institution0.05%151,977
35,652Institution0.03%79,860
21,857Institution0.02%48,960

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,745,090Institution1.39%4,973,507
1,281,812Institution1.02%2,871,259
670,132Institution0.53%1,909,876
519,943Institution0.41%1,164,672
439,445Institution0.35%984,357
223,665Institution0.18%637,445
138,476Institution0.11%310,186
111,984Institution0.09%250,844
82,047Institution0.07%188,708
75,635Institution0.06%186,062

FAQ

Who Owns Nautilus Biotechnolgy (NAUT)?
According to the latest TipRanks data, approximately 41.86% of the company's stock is held by institutional investors, 42.95% is held by insiders, and 6.99% is held by retail investors.
    What percentage of Nautilus Biotechnolgy (NAUT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 41.86% of Nautilus Biotechnolgy (NAUT) stock is held by institutional investors.
      What percentage of Nautilus Biotechnolgy (NAUT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 6.99% of Nautilus Biotechnolgy (NAUT) stock is held by retail investors.
        Who owns the most shares of Nautilus Biotechnolgy (NAUT)?
        Parag Mallick owns the most shares of Nautilus Biotechnolgy (NAUT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis